This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): AZD0837
Description: AZD0837 is oral direct thrombin inhibitor follow-up to EXANTA.
Pink Sheet Exanta NDA dropped due to liver injury
Additional information available to subscribers only: